BarryDeanBertoletMD
Cardiology • Tupelo, MSAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Program Director , NMMC Cardiovascular Fellowship Program
Dr. Bertolet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
499 Gloster Creek Village A-2
Cardiology Associates Of N. Ms, Pa
Tupelo, MS 38801Phone+1 662-620-6800Fax+1 662-620-6950
Education & Training
University of FloridaFellowship, Cardiovascular Disease, 1990 - 1993- University of FloridaResidency, Internal Medicine, 1986 - 1990
University of Mississippi School of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1987 - 2026
MS State Medical License 1987 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2014
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Access Safety and Efficacy Post Endovascular Intervention Start of enrollment: 2012 Dec 01
- AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN Start of enrollment: 2013 Dec 01
- VASCADE ANTEGRADE-PVD Post-Market Registry Start of enrollment: 2017 Jan 19
Publications & Presentations
PubMed
- 54 citationsBradycardia after heart transplantation: Reversal with theophyllineBarry D. Bertolet, David A. Eagle, Jamie B. Conti, Roger M. Mills, Luiz Belardinelli
Journal of the American College of Cardiology. 1996-08-01 - 41 citationsTheophylline for the treatment of atrioventricular block after myocardial infarction.Barry D. Bertolet, Elzbieta B. McMurtrie, James A. Hill, Luiz Belardinelli
Annals of Internal Medicine. 1995-10-01 - 208 citationsPivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II).Jeffrey W. Chambers, Robert L. Feldman, Stevan I. Himmelstein, Rohit Bhatheja, Augusto E. Villa
JACC. Cardiovascular Interventions. 2014-05-01
Journal Articles
- Coronary Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary AngiographySomjot Brar, Hitinder S Gurm, Barry Bertolet, Anand Prasad, Dominick J Angiolillo, Roxana Mehran, George Dangas, Wayne Batchelor, Gregg W Stone, ScienceDirect
Press Mentions
| Newsmakers |June 26th, 2022- Canon Medical Introduces Alphenix Sky 12 HD Interventional System with the New 12”×12” High-Definition (Hi-Def) DetectorSeptember 15th, 2023
- NMMC Debuts Groundbreaking Procedure to Treat High Blood PressureDecember 8th, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
